Livongo Health, a Mountain View, CA-based consumer digital health company, secured $20m in Series B funding.
Backers included Kleiner Perkins Caufield & Byers, DFJ and previous investor General Catalyst.
The company intends to use the funds to further develop its chronic disease management ecosystem and accelerate the adoption of its digital diabetes management program, Livongo for Diabetes™, among self-insured employers, healthcare providers and payers. In conjunction with the funding, Dr. Beth Seidenberg, General Partner at KPCB, and Emily Melton, Partner at DFJ, will be joining Livongo Health’s Board of Directors.
Launched in September 2014 by Glen Tullman, Chief Executive Officer, Livongo Health provides people with a digital platform to manage chronic conditions, beginning with diabetes.
Livongo for Diabetes is the company’s initial product offering, a diabetes management program targeted to people with either Type 1 or Type 2 diabetes to manage important aspects of their illness on their own. It also allows them to keep their family members and care team informed in real-time.
Each user receives a blood glucose smartmeter, which captures a user’s biometric data and uploads it to a cloud-based inference engine where historical data, clinical rules and predictive modeling are used to convert it into information and support.
To date, the company has signed agreements for employees of self-insured employers such as Office Depot, Iron Mountain and multiple Fortune 100 companies.